The splenomegaly therapeutics market will register a CAGR of almost 3% by 2023

Wednesday, April 3, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, April 2, 2019 /PRNewswire/ -- About this marketThe availability of clinical practice guidelines improves the

quality of life of patients, as well as the consistency of care. There are several guidelines and care pathways for the management of splenomegaly, which have been developed by hospitals and professional societies. These are published and practiced with
the aim of standardizing disease management in patients with splenomegaly. For instance, the Hospital for Sick Children has developed a clinical practice guideline for clinicians to provide adequate disease management in children with splenomegaly. In developing countries such as India, the Association of Physicians of India published guidelines for a clinical approach for appropriate diagnosis and management of splenomegaly. Analysts have predicted that the splenomegaly therapeutics market will register a CAGR of almost 3% by 2023.Download the full report: https://www.reportbuyer.com/product/5761953/?utm_source=PRN Market OverviewRising awareness of splenomegalyThe incidence of splenomegaly has been seen along with many primary indications, including infections, autoimmune disorders, and hematological malignancies, which are increasing globally. Hence, the governments of various countries and several non-governmental organizations are striving to increase patient awareness about splenomegaly.Challenges associated with diagnosis of splenomegalySplenomegaly is a nonspecific finding, which is challenging to assess diagnostically, as it is generally a manifestation of an underlying primary disorder. The highly advanced procedures such as point-of-care ultrasonography for the diagnosis for splenomegaly have high sensitivity compared with conventional imaging techniques. However, the poor patient access because of the high cost limits their utilization in diagnosing splenomegaly.For the detailed list of factors that will drive and challenge the growth of the splenomegaly therapeutics market during the 2019-2023, view our report.Competitive LandscapeThe market appears to be fairly fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.Download the full report: https://www.reportbuyer.com/product/5761953/?utm_source=PRN About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-splenomegaly-therapeutics-market-will-register-a-cagr-of-almost-3-by-2023-300823035.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store